Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC), 37877 [2019-16534]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 149 / Friday, August 2, 2019 / Notices
Federal agencies, and State and local
public agencies, regarding activities
relating to the effect of cigarette smoking
on human health.
Matters To Be Considered: The agenda
will include discussions on
‘‘Empowering Youth and Youth
Influencers to Prevent the Use of
Emerging Tobacco Products’’ and the
objective of the meeting is Identify
federal actions to empower youth,
parents, educators, health care
professionals, and others who influence
youth and young adults to prevent the
initiation and use of e-cigarettes and
other emerging tobacco products.
Requests to make oral presentations
should be submitted in writing to the
contact person listed. All requests must
contain the name, address, telephone
number, and organizational affiliation of
the presenter. Agenda items are subject
to change as priorities dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–16536 Filed 8–1–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Injury Prevention
and Control, (BSC, NCIPC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of closed meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
National Center for Injury Prevention
and Control, (BSC, NCIPC).
DATES: The meeting will be held on
August 27, 2019 09:00 a.m. to 05:00
p.m., EDT (CLOSED).
ADDRESSES: In-Person and
Teleconference; 4770 Buford Highway
NE, Atlanta, GA 30341.
FOR FURTHER INFORMATION CONTACT:
Gwendolyn H. Cattledge, Ph.D.,
jbell on DSK3GLQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:02 Aug 01, 2019
Jkt 247001
M.S.E.H., Deputy Associate Director for
Science, NCIPC, CDC, 4770 Buford
Highway NE, Mailstop F–63, Atlanta,
GA 30341, Telephone (770) 488–3953,
Email address: NCIPCBSC@cdc.gov.
SUPPLEMENTARY INFORMATION: The
meeting will be closed to the public in
accordance with provisions set forth in
Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the
Chief Operating Officer, Office of the
Chief Operating Officer, CDC, pursuant
to Public Law 92–463.
Purpose: The Board will: (1) Conduct,
encourage, cooperate with, and assist
other appropriate public health
authorities, scientific institutions, and
scientists in the conduct of research,
investigations, experiments,
demonstrations, and studies relating to
the causes, diagnosis, treatment, control,
and prevention of physical and mental
diseases, and other impairments; (2)
assist States and their political
subdivisions in preventing and
suppressing communicable and noncommunicable diseases and other
preventable conditions and in
promoting health and well-being; and
(3) conduct and assist in research and
control activities related to injury. The
BSC, NCIPC makes recommendations
regarding policies, strategies, objectives,
and priorities; and reviews progress
toward injury prevention goals and
provides evidence in injury preventionrelated research and programs. The
Board also provides advice on the
appropriate balance of intramural and
extramural research, and the structure,
progress and performance of intramural
programs. The Board is designed to
provide guidance on extramural
scientific program matters, including
the: (1) Review of extramural research
concepts for funding opportunity
announcements; (2) conduct of
Secondary Peer Review of extramural
research grants, cooperative agreements,
and contracts applications received in
response to funding opportunity
announcements as they relate to the
Center’s programmatic balance and
mission; (3) submission of secondary
review recommendations to the Center
Director of applications to be considered
for funding support; (4) review of
research portfolios, and (5) review of
program proposals.
Matters To Be Considered: The agenda
will include discussions on Secondary
Peer Review of extramural research
grant and cooperative agreement
applications received in response to five
(5) Notice of Funding Opportunities
(NOFO): RFA–CE19–002—Research
Grants to Identify Effective Strategies for
Opioid Overdose Prevention; RFA–
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
37877
CE19–003—Evaluation of Return to
School Programs for Traumatic Brain
Injury; RFA–CE19–005—Research
Grants for Preventing Violence and
Violence-Related Injury (R01); RFA–
CE19–006—Grants to Support New
Investigators in Addressing CrossCutting Violence Prevention and Opioid
Overdose Prevention and; funding
notices for Small Business Innovation
Research—PA–18–573–PHS 2018–02
Omnibus Solicitation of the NIH for
Small Business Innovation Research
Grant Applications (Parent SBIR [R43/
R44] Clinical Trial Required) and/or
PA–18–574–PHS 2018–02 Omnibus
Solicitation of the NIH, CDC, and FDA
for Small Business Innovation Research
Grant Applications (Parent SBIR [R43/
R44] Clinical Trial Not Allowed).
Agenda items are subject to change as
priorities dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–16534 Filed 8–1–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Institute for Occupational
Safety and Health (BSC, NIOSH)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
of the Board of Scientific Counselors,
National Institute for Occupational
Safety and Health (BSC, NIOSH). This
meeting is open to the public, limited
only by the space available. The meeting
room accommodates approximately 33
people. The meeting is also open to the
public via webcast. If you wish to attend
in person or by webcast, please see the
NIOSH website to register (https://
www.cdc.gov/niosh/bsc/) or call (404–
498–2539) at least five business days in
advance of the meeting. Teleconference
SUMMARY:
E:\FR\FM\02AUN1.SGM
02AUN1
]]>Agencies
[Federal Register Volume 84, Number 149 (Friday, August 2, 2019)]
[Notices]
[Page 37877]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-16534]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Injury
Prevention and Control, (BSC, NCIPC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of closed meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Board of Scientific Counselors,
National Center for Injury Prevention and Control, (BSC, NCIPC).
DATES: The meeting will be held on August 27, 2019 09:00 a.m. to 05:00
p.m., EDT (CLOSED).
ADDRESSES: In-Person and Teleconference; 4770 Buford Highway NE,
Atlanta, GA 30341.
FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770
Buford Highway NE, Mailstop F-63, Atlanta, GA 30341, Telephone (770)
488-3953, Email address: [email protected].
SUPPLEMENTARY INFORMATION: The meeting will be closed to the public in
accordance with provisions set forth in Section 552b(c)(4) and (6),
Title 5 U.S.C., and the Determination of the Chief Operating Officer,
Office of the Chief Operating Officer, CDC, pursuant to Public Law 92-
463.
Purpose: The Board will: (1) Conduct, encourage, cooperate with,
and assist other appropriate public health authorities, scientific
institutions, and scientists in the conduct of research,
investigations, experiments, demonstrations, and studies relating to
the causes, diagnosis, treatment, control, and prevention of physical
and mental diseases, and other impairments; (2) assist States and their
political subdivisions in preventing and suppressing communicable and
non-communicable diseases and other preventable conditions and in
promoting health and well-being; and (3) conduct and assist in research
and control activities related to injury. The BSC, NCIPC makes
recommendations regarding policies, strategies, objectives, and
priorities; and reviews progress toward injury prevention goals and
provides evidence in injury prevention-related research and programs.
The Board also provides advice on the appropriate balance of intramural
and extramural research, and the structure, progress and performance of
intramural programs. The Board is designed to provide guidance on
extramural scientific program matters, including the: (1) Review of
extramural research concepts for funding opportunity announcements; (2)
conduct of Secondary Peer Review of extramural research grants,
cooperative agreements, and contracts applications received in response
to funding opportunity announcements as they relate to the Center's
programmatic balance and mission; (3) submission of secondary review
recommendations to the Center Director of applications to be considered
for funding support; (4) review of research portfolios, and (5) review
of program proposals.
Matters To Be Considered: The agenda will include discussions on
Secondary Peer Review of extramural research grant and cooperative
agreement applications received in response to five (5) Notice of
Funding Opportunities (NOFO): RFA-CE19-002--Research Grants to Identify
Effective Strategies for Opioid Overdose Prevention; RFA-CE19-003--
Evaluation of Return to School Programs for Traumatic Brain Injury;
RFA-CE19-005--Research Grants for Preventing Violence and Violence-
Related Injury (R01); RFA-CE19-006--Grants to Support New Investigators
in Addressing Cross-Cutting Violence Prevention and Opioid Overdose
Prevention and; funding notices for Small Business Innovation
Research--PA-18-573-PHS 2018-02 Omnibus Solicitation of the NIH for
Small Business Innovation Research Grant Applications (Parent SBIR
[R43/R44] Clinical Trial Required) and/or PA-18-574-PHS 2018-02 Omnibus
Solicitation of the NIH, CDC, and FDA for Small Business Innovation
Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not
Allowed). Agenda items are subject to change as priorities dictate.
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-16534 Filed 8-1-19; 8:45 am]
BILLING CODE 4163-18-P
